ArticleBiology direct2026
NCOA4-mediated ferritinophagy modulates colitis-associated ferroptosis in intestinal epithelial cells and mucosal repair.
Article in Biology direct, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Emerging Role of Ferroptosis in Chemotherapy-Associated Hepatorenal Toxicity: Mechanistic Insights and Toxicological Perspectives.ACS pharmacology & translational science · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundFerroptosis in intestinal epithelial cells (IECs) acts as a crucial mechanism driving intestinal mucosal injuries and inflammatory reactions in colitis. Nuclear receptor coactivator 4 (NCOA4)-mediated ferritinophagy, a primary pathway for intracellular iron storage, takes part in regulating ferroptosis. Nevertheless, it is yet unknown whether ferritinophagy plays a role in ferroptosis of IECs in colitis. Hence, this experiment used dextran sulfate sodium salt (DSS) to establish an inflammation model with NCM460 cells and an animal model of colitis to discover the role of ferritinophagy in ferroptosis in IECs and colonic mucosal inflammatory damage.
resultsDSS induced ferroptosis in IECs, presenting as significantly increased contents of Fe2+, reactive oxygen species (ROS), and malondialdehyde (MDA), decreased protein expression of glutathione peroxidase 4 (GPX4), and increased expression of cyclooxygenase-2 (COX2) (all P<0.05). Moreover, administration of ferroptosis inhibitor liproxstatin-1 and autophagy inhibitor methyladenine (3-MA) ameliorated colonic tissue damage in the animal model of colitis, reducing the disease activity index (DAI), colon macroscopic damage index (CMDI), and pathological score, as well as the serum contents of mucosal permeability markers diamine oxidase (DAO) and D-lactic acid (D-LA) (all P<0.05). Further, knockdown of NCOA4 downregulated the expression of microtubule-associated protein light chain 3 (LC3) and autophagy-related protein 5 (ATG5) proteins, upregulated the expression of ferritin heavy chain 1 (FTH1), inhibited ferritinophagy, and decreased ferroptosis in IECs induced by DSS, thus ameliorating colonic inflammatory damage and mucosal permeability (all P<0.05). On the contrary, overexpression of NCOA4 encouraged ferritinophagy and aggravated ferroptosis in IECs and intestinal damage.
conclusionsThis study provided evidence supporting that NCOA4-mediated ferritinophagy participates in modulating colitis-related ferroptosis in IECs, and suppressing ferritinophagy protects IECs and promotes colonic mucosal repair.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.